NsGene

closed

NsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.

Launch date

Jan 1999

Employees

Market cap

Enterprise valuation

Company register number 21479195

Ballerup Capital Region of Denmark (HQ)

http://nsgene.dk

https://www.linkedin.com/company/nsgene-as

Revenues, earnings & profits over time

DKK	2013	2014	2015
Revenues	11.8m	9.2m	12.0m
% growth	-	(22 %)	31 %
Profit	4.9m	8.4m	11.6m
% profit margin	41 %	92 %	97 %

Date	Investors	Amount	Round
-	Nordic Biotech	N/A	-
May 2005	DKA Capital Neurosearch VF Venture (Vækstfonden) Karolinska Development	$5.1m	Early VC
Nov 2013	N/A	$550k	Grant
Total Funding		AUD8.8m

Tech stackLearn more about the technologies and tools that this company uses.